Mutual of America Capital Management LLC Sells 506 Shares of Silicon Laboratories, Inc. $SLAB

Mutual of America Capital Management LLC cut its stake in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB) by 3.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,198 shares of the semiconductor company’s stock after selling 506 shares during the period. Mutual of America Capital Management LLC’s holdings in Silicon Laboratories were worth $2,387,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of SLAB. Allianz Asset Management GmbH raised its stake in shares of Silicon Laboratories by 9.2% during the 2nd quarter. Allianz Asset Management GmbH now owns 167,835 shares of the semiconductor company’s stock worth $24,732,000 after purchasing an additional 14,077 shares during the period. Davidson Investment Advisors raised its stake in shares of Silicon Laboratories by 1.0% during the 2nd quarter. Davidson Investment Advisors now owns 145,982 shares of the semiconductor company’s stock worth $21,512,000 after purchasing an additional 1,480 shares during the period. Bayforest Capital Ltd raised its stake in shares of Silicon Laboratories by 276.5% during the 2nd quarter. Bayforest Capital Ltd now owns 7,542 shares of the semiconductor company’s stock worth $1,111,000 after purchasing an additional 5,539 shares during the period. CWM LLC raised its stake in shares of Silicon Laboratories by 137.0% during the 2nd quarter. CWM LLC now owns 2,237 shares of the semiconductor company’s stock worth $330,000 after purchasing an additional 1,293 shares during the period. Finally, Vanguard Personalized Indexing Management LLC raised its stake in shares of Silicon Laboratories by 24.6% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 4,571 shares of the semiconductor company’s stock worth $674,000 after purchasing an additional 901 shares during the period.

Insider Activity at Silicon Laboratories

In related news, SVP Brandon Tolany sold 8,000 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $145.23, for a total transaction of $1,161,840.00. Following the completion of the sale, the senior vice president owned 62,328 shares in the company, valued at approximately $9,051,895.44. This trade represents a 11.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders sold a total of 12,070 shares of company stock valued at $1,703,472 over the last 90 days. 1.60% of the stock is owned by company insiders.

Silicon Laboratories Stock Performance

Shares of SLAB stock opened at $135.12 on Friday. Silicon Laboratories, Inc. has a fifty-two week low of $82.82 and a fifty-two week high of $160.00. The company has a market capitalization of $4.43 billion, a P/E ratio of -41.96 and a beta of 1.51. The stock has a 50 day moving average price of $134.39 and a two-hundred day moving average price of $129.10.

Silicon Laboratories (NASDAQ:SLAB) last posted its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $0.11 EPS for the quarter, topping the consensus estimate of $0.09 by $0.02. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The business had revenue of $192.85 million for the quarter, compared to analyst estimates of $192.57 million. During the same quarter in the previous year, the firm posted ($0.56) earnings per share. Silicon Laboratories’s quarterly revenue was up 32.6% on a year-over-year basis. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. As a group, equities analysts predict that Silicon Laboratories, Inc. will post -0.97 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently commented on SLAB. Barclays lifted their target price on Silicon Laboratories from $100.00 to $130.00 and gave the stock an “equal weight” rating in a research note on Tuesday, August 5th. Stifel Nicolaus lifted their target price on Silicon Laboratories from $144.00 to $160.00 and gave the stock a “buy” rating in a research note on Friday, July 18th. Morgan Stanley lowered their target price on Silicon Laboratories from $157.00 to $144.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 6th. Weiss Ratings reissued a “sell (d-)” rating on shares of Silicon Laboratories in a report on Saturday. Finally, Susquehanna lifted their price objective on Silicon Laboratories from $110.00 to $150.00 and gave the stock a “neutral” rating in a report on Tuesday, July 22nd. Five investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $151.13.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.